Literature DB >> 28540584

[Interstitial cystitis : Diagnosis and pharmacological and surgical therapy].

A Gonsior1, J Neuhaus2, L C Horn3, T Bschleipfer4, J-U Stolzenburg2.   

Abstract

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic debilitating condition which generally has a severely negative impact on quality of life. An autoimmune genetic predisposition correlates with the theory of pathogenesis. Diagnosis requires history, diaries, physical examination, exclusion of other diseases, cystoscopy with or without hydrodistension and/or bladder biopsy. Novel biological markers are upcoming but not established. Behavioural, pharmacological oral and intravesical, interventional and surgical therapies with a wide range of reported success are available. A multimodal approach is recommended, although most of the therapeutic options lack a high degree of evidence.

Entities:  

Keywords:  Bladder pain syndrome; Chronic pelvic pain; Diagnostics; Interstitial cystitis; Therapeutics

Mesh:

Substances:

Year:  2017        PMID: 28540584     DOI: 10.1007/s00120-017-0408-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  70 in total

1.  Heparin and alkalinized lidocaine versus alkalinized lidocaine for treatment of interstitial cystitis symptoms.

Authors:  C Lowell Parsons; James A Koziol; Jeffrey G Proctor; Paul Zupkas; Sulabha Argade
Journal:  Can J Urol       Date:  2015-04       Impact factor: 1.344

Review 2.  The epidemiology of interstitial cystitis: is it time to expand our definition?

Authors:  J W Kusek; L M Nyberg
Journal:  Urology       Date:  2001-06       Impact factor: 2.649

3.  Treatment of interstitial cystitis: comparison of subtrigonal and supratrigonal cystectomy combined with orthotopic bladder substitution.

Authors:  J F Linn; M Hohenfellner; S Roth; S E Dahms; R Stein; L Hertle; J W Thüroff; R Hohenfellner
Journal:  J Urol       Date:  1998-03       Impact factor: 7.450

4.  Bilateral S3 stimulator in patients with interstitial cystitis.

Authors:  Adam C Steinberg; Ian A Oyama; Kristene E Whitmore
Journal:  Urology       Date:  2007-03       Impact factor: 2.649

5.  Efficacy and safety of augmentation ileocystoplasty combined with supratrigonal cystectomy for the treatment of refractory bladder pain syndrome/interstitial cystitis with Hunner's lesion.

Authors:  Hyung Joon Kim; Jae Seong Lee; Won Jin Cho; Hyo Serk Lee; Ha Na Lee; Hyun Wook You; Wonho Jung; Kyu-Sung Lee
Journal:  Int J Urol       Date:  2014-04       Impact factor: 3.369

6.  Prevalence of Ureaplasma urealyticum and Mycoplasma hominis in women with chronic urinary symptoms.

Authors:  Stavroula Baka; Evangelia Kouskouni; Stavroula Antonopoulou; Dimos Sioutis; Margenti Papakonstantinou; Dimitris Hassiakos; Emmanuel Logothetis; Angelos Liapis
Journal:  Urology       Date:  2009-04-15       Impact factor: 2.649

Review 7.  Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal.

Authors:  Joop P van de Merwe; Jørgen Nordling; Pierre Bouchelouche; Kirsten Bouchelouche; Mauro Cervigni; L Kurosch Daha; Suzy Elneil; Magnus Fall; Gero Hohlbrugger; Paul Irwin; Svend Mortensen; Arndt van Ophoven; John L Osborne; Ralph Peeker; Benedikte Richter; Claus Riedl; Jukka Sairanen; Martina Tinzl; Jean-Jacques Wyndaele
Journal:  Eur Urol       Date:  2007-09-20       Impact factor: 20.096

8.  Patient perceived outcomes of treatments used for interstitial cystitis.

Authors:  Jennifer R Hill; Ginger Isom-Batz; Georgia Panagopoulos; Kay Zakariasen; Elizabeth Kavaler
Journal:  Urology       Date:  2008-01       Impact factor: 2.649

Review 9.  Intravesical treatments of bladder pain syndrome/interstitial cystitis.

Authors:  Jochen Neuhaus; Thilo Schwalenberg
Journal:  Nat Rev Urol       Date:  2012-11-27       Impact factor: 14.432

10.  Stool-based biomarkers of interstitial cystitis/bladder pain syndrome.

Authors:  A Braundmeier-Fleming; Nathan T Russell; Wenbin Yang; Megan Y Nas; Ryan E Yaggie; Matthew Berry; Laurie Bachrach; Sarah C Flury; Darlene S Marko; Colleen B Bushell; Michael E Welge; Bryan A White; Anthony J Schaeffer; David J Klumpp
Journal:  Sci Rep       Date:  2016-05-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.